Cofactor leverages the power of RNA to model disease. Cofactor builds expression models that interpret the dynamic, complex data that defines a state of health. One of Cofactor’s key products, ImmunoPrism, is an immune profiling assay that overcomes the limitations with previous technologies. ImmunoPrism is available as a clinical assay as well as a research kit for use in the thousands of labs profiling tumors. Additional kits and clinical assays built on Cofactor’s Prism Database of RNA models are slated for future release. Cofactor is leveraging its database of RNA models to predict drug response for the 95% of diseases that cannot be assessed by DNA alone. Cofactor’s team includes former Human Genome Project scientists.